Literature DB >> 28795301

Organotypic Cultures from the Adult CNS: A Novel Model to Study Demyelination and Remyelination Ex Vivo.

Glaiza A Tan1,2, Kendra L Furber3,4, Merlin P Thangaraj1,2, LaRhonda Sobchishin1,2, J Ronald Doucette5,2,6, Adil J Nazarali1,2,6.   

Abstract

Experimental models of multiple sclerosis (MS) have significantly advanced our understanding of pathophysiology and therapeutic interventions. Although in vivo rodent models are considered to most closely represent the complex cellular and molecular disease states of the human central nervous system (CNS), these can be costly to maintain and require long timelines. Organotypic slice cultures maintain the cytotypic organization observed in the intact CNS, yet provide many of the experimental advantages of in vitro cell culture models. Cerebellar organotypic cultures have proven useful for studying myelination and remyelination, but this model has only been established using early postnatal tissue. This young brain tissue allows for neuro development ex vivo to mimic the 'mature' CNS; however, there are many differences between postnatal and adult organotypic cultures. This may be particularly relevant to MS, as a major barrier to myelin regeneration is age. This paper describes a modified protocol to study demyelination and remyelination in adult cerebellar tissue, which has been used to demonstrate neuroprotection with omega-3 fatty acids. Thus, adult cerebellar organotypic cultures provide a novel ex vivo platform for screening potential therapies in myelin degeneration and repair.

Entities:  

Keywords:  Central nervous system; Multiple sclerosis; Myelination; Organotypic slice culture

Mesh:

Year:  2017        PMID: 28795301     DOI: 10.1007/s10571-017-0529-6

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  83 in total

1.  Lysolecithin induces demyelination in vitro in a cerebellar slice culture system.

Authors:  Eric Birgbauer; Tadimeti S Rao; Michael Webb
Journal:  J Neurosci Res       Date:  2004-10-15       Impact factor: 4.164

Review 2.  Pathology of demyelinating diseases.

Authors:  Bogdan F Gh Popescu; Claudia F Lucchinetti
Journal:  Annu Rev Pathol       Date:  2012       Impact factor: 23.472

3.  Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination.

Authors:  S A Shields; J M Gilson; W F Blakemore; R J Franklin
Journal:  Glia       Date:  1999-10       Impact factor: 7.452

4.  Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling.

Authors:  Catherine O'Sullivan; Kumlesh K Dev
Journal:  J Cell Sci       Date:  2015-09-10       Impact factor: 5.285

5.  Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes.

Authors:  D E Williard; S D Harmon; T L Kaduce; M Preuss; S A Moore; M E Robbins; A A Spector
Journal:  J Lipid Res       Date:  2001-09       Impact factor: 5.922

6.  Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats.

Authors:  G L Hinks; R J Franklin
Journal:  Mol Cell Neurosci       Date:  2000-11       Impact factor: 4.314

7.  Cyclin-dependent kinase 5 mediates adult OPC maturation and myelin repair through modulation of Akt and GsK-3β signaling.

Authors:  FuCheng Luo; Kathryn Burke; Christopher Kantor; Robert H Miller; Yan Yang
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

8.  Ethyl-eicosapentaenoic acid ameliorates the clinical course of experimental allergic encephalomyelitis induced in dark agouti rats.

Authors:  Serafina Salvati; Antonella Di Biase; Lucilla Attorri; Rita Di Benedetto; Massimo Sanchez; Luca Lorenzini; Marco Alessandri; Laura Calzà
Journal:  J Nutr Biochem       Date:  2013-05-01       Impact factor: 6.048

9.  Lactate induced excitotoxicity in hippocampal slice cultures.

Authors:  Zhongmin Xiang; Maoli Yuan; Getaw W Hassen; Mordechai Gampel; Peter J Bergold
Journal:  Exp Neurol       Date:  2004-03       Impact factor: 5.330

10.  Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination.

Authors:  Chao Zhao; Wen-Wu Li; Robin J M Franklin
Journal:  Neurobiol Aging       Date:  2005-07-26       Impact factor: 4.673

View more
  6 in total

Review 1.  A Bridge Between in vitro and in vivo Studies in Neuroscience: Organotypic Brain Slice Cultures.

Authors:  Merve AlaylioĞlu; Erdinç Dursun; Selma Yilmazer; Duygu Gezen Ak
Journal:  Noro Psikiyatr Ars       Date:  2020-09-21       Impact factor: 1.339

Review 2.  Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis: Aloe vera and Citrus bergamia as Potential Candidates for Intestinal Health.

Authors:  Jessica Maiuolo; Vincenzo Musolino; Micaela Gliozzi; Cristina Carresi; Federica Scarano; Saverio Nucera; Miriam Scicchitano; Francesca Oppedisano; Francesca Bosco; Roberta Macri; Ernesto Palma; Carolina Muscoli; Vincenzo Mollace
Journal:  Nutrients       Date:  2022-06-29       Impact factor: 6.706

3.  Membrane Protein Identification in Rodent Brain Tissue Samples and Acute Brain Slices.

Authors:  Sarah Joost; Stefan Mikkat; Michael Wille; Antje Schümann; Oliver Schmitt
Journal:  Cells       Date:  2019-05-08       Impact factor: 6.600

Review 4.  Tissue Response to Neural Implants: The Use of Model Systems Toward New Design Solutions of Implantable Microelectrodes.

Authors:  Maurizio Gulino; Donghoon Kim; Salvador Pané; Sofia Duque Santos; Ana Paula Pêgo
Journal:  Front Neurosci       Date:  2019-07-05       Impact factor: 4.677

Review 5.  In vitro Models of Neurodegenerative Diseases.

Authors:  Anna Slanzi; Giulia Iannoto; Barbara Rossi; Elena Zenaro; Gabriela Constantin
Journal:  Front Cell Dev Biol       Date:  2020-05-13

6.  Assessing the Potential of Molecular Imaging for Myelin Quantification in Organotypic Cultures.

Authors:  Ander Egimendia; Susana Carregal-Romero; Iñaki Osorio-Querejeta; Daniel Padro; Jesús Ruiz-Cabello; David Otaegui; Pedro Ramos-Cabrer
Journal:  Pharmaceutics       Date:  2021-06-28       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.